Viewing Study NCT05567458


Ignite Creation Date: 2025-12-25 @ 12:14 AM
Ignite Modification Date: 2026-01-07 @ 3:33 AM
Study NCT ID: NCT05567458
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-08-12
First Post: 2022-10-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate Luspatercept (ACE-536) in Chinese Participants Who Require Regular Red Blood Cell Transfusions Due to Beta (β)-Thalassemia.
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module